The upregulation of FLT3, MYB, DNMT3B, and MYCN oncogenes was also seen in the DX and paired CR1 DEG profiling, reiterating their potentiality for MRD monitoring in AML-NK patients. The gene discussed is MYB; the disease is acute myeloid leukemia.